Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?

Lipoprotein apheresis (LA) is an effective tool to reduce cardiovascular events (CVEs) in high-risk patients with elevations of low density lipoprotein-cholesterol (LDL-C) and/or Lipoprotein(a) (Lp(a)). All patients included into this retrospective analysis had experienced CVEs before the start of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Julius, Ulrich, Kuss, Solveig, Tselmin, Sergey, Schatz, Ulrike, Bornstein, Stefan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569841/
https://www.ncbi.nlm.nih.gov/pubmed/32708542
http://dx.doi.org/10.3390/jcdd7030025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569841/
https://www.ncbi.nlm.nih.gov/pubmed/32708542
http://dx.doi.org/10.3390/jcdd7030025

Ejemplares similares